Our Story So Far

Early 2018

Meta Healthcare was founded with the vision of becoming a preferred partner in the development and commercialisation of innovative metabolic medicines.

Mid 2018

APR becomes our partner.

Mid 2018

In Vitro experimentation - "A New Phe-Free Protein Substitute”

September 2019

Sponsorship at SSIEM Rotterdam conference.



April 2020

PKU GOLIKE Plus 3‐16 approved in the UK.

September 2020

PKU GoLike Plus 3‐16 sampling program in the UK.

October 2020

PKU GOLIKE Plus 3‐16 commercial launch in the UK.



Thinking about the future - PKU GOLIKE Plus 16+ expected commercial launch in the UK

Meta Healthcare LTD © 2024

Terms & Conditions
Meta Healthcare Disclaimer

Meta Healthcare Ltd informs that the following pages are reserved to Health Care Professional (HCP’s) and PKU patients and carers.

In no event, Meta Healthcare Ltd. and its affiliated companies shall be liable for any use or exploitation of the information contained in the following pages if not previously authorized in writing by Meta Healthcare Ltd. 

By clicking on the following link you declare under your own responsibility to be an HCP, PKU patient or carer and to accept the conditions here above described.